Skip to main content
In stock | Hormonal Therapy

Imlunestrant

Oncology Type Solid Tumour (Breast)
Drug Class / Mechanism Selective Estrogen Receptor Degrader (SERD)
No Image
Description

Imlunestrant is classified as a Selective Estrogen Receptor Degrader (SERD), sourced for use within our Hormonal Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Hormonal Therapy
Oncology Type Solid Tumour (Breast)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3